{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:08:04Z","timestamp":1775815684443,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Youth Innovation Project of Fujian Provincial Natural Science Foundation","award":["2022J05293"],"award-info":[{"award-number":["2022J05293"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute myocardial infarction (AMI) is a serious cardiovascular disease that adversely affects human health. Circular RNAs (circRNAs) are involved in the pathological and physiological processes of AMI, but the biological mechanism of their involvement and their clinical significance remain unknown. We aimed to identify circRNAs that are significantly associated with morbidity in the peripheral blood of patients with AMI and evaluate their diagnostic utility.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>High-throughput sequencing was used to screen for differentially expressed circRNAs in peripheral blood samples obtained from five patients with AMI and five sex- and age-matched healthy controls. A series of bioinformatics tools and databases were used to determine the biological functional classification and pathway enrichment of the circRNAs based on data obtained from sequencing. A hypoxia model was established and used to evaluate the effect of hypoxia on circRNA expression in human cardiomyocytes. A cytoplasmic separation assay and enzyme resistance assay were employed to identify the biological characteristics of circRNA. Polymerase chain reaction validity testing and receiver operating characteristic (ROC) curve analysis were used to evaluate the utility of circRNA assessments in the diagnosis of AMI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A large number of circRNAs were found to be differentially expressed in the peripheral blood of patients with AMI, and significantly more of these circRNAs were highly expressed than lowly expressed. The genes encoding these circRNAs have a wide range of effects on various functions in the body. A hypoxic environment promoted the upregulation of circRNA expression in human cardiomyocytes, and hsa_circ_0116795 encoded by <jats:italic>PPARA<\/jats:italic> was highly expressed in the peripheral blood of the patients with AMI. In terms of biological characteristics, under physiological conditions, hsa_circ_0116795 (circ_PPARA) was mainly located in the cytoplasm of cardiomyocytes and found to be resistant to exonuclease. The ROC curve analysis showed that the expression levels of circ_PPARA in the peripheral blood of patients with AMI were significantly different from those in the peripheral blood of healthy controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A large number of abnormally expressed circRNAs are detectable in the peripheral blood of patients with AMI. In particular, circ_PPARA is highly expressed in human myocardial cells under hypoxic conditions, and its biological characteristics indicate that it could be employed as a biomarker for the early diagnosis of AMI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-024-01753-3","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T06:43:33Z","timestamp":1710225813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hypoxia-induced circRNAs encoded by PPARA are highly expressed in human cardiomyocytes and are potential clinical biomarkers of acute myocardial infarction"],"prefix":"10.1186","volume":"29","author":[{"given":"Shasha","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"1753_CR1","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.jacc.2021.03.003","volume":"77","author":"HL Dauerman","year":"2021","unstructured":"Dauerman HL, Ibanez B. The edge of time in acute myocardial infarction. J Am Coll Cardiol. 2021;77:1871\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"1753_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/1074248415616187","volume":"21","author":"RA Kloner","year":"2016","unstructured":"Kloner RA, Dai W, Hale SL, Shi J. Approaches to improving cardiac structure and function during and after an acute myocardial infarction: acute and chronic phases. J Cardiovasc Pharmacol Ther. 2016;21:363\u20137.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"1753_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12872-023-03105-1","volume":"23","author":"C Wu","year":"2023","unstructured":"Wu C, Li L, Wang S, Zeng J, Yang J, Xu H, et al. Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China acute myocardial infarction registry. BMC Cardiovasc Disord. 2023;23:103.","journal-title":"BMC Cardiovasc Disord"},{"key":"1753_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12916-022-02418-w","volume":"20","author":"S Li","year":"2022","unstructured":"Li S, Gao X, Yang J, Xu H, Wang Y, Zhao Y, et al. Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China acute myocardial infarction registry. BMC Med. 2022;20:217.","journal-title":"BMC Med"},{"key":"1753_CR5","doi-asserted-by":"publisher","first-page":"1285558","DOI":"10.3389\/fpubh.2023.1285558","volume":"11","author":"W Jian","year":"2023","unstructured":"Jian W, Zhou W, Zhang L. The impact of centralized coronary stent procurement program on acute myocardial infarction treatments: evidence from China. Front Public Health. 2023;11:1285558.","journal-title":"Front Public Health"},{"key":"1753_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphys.2019.00123","volume":"10","author":"S Xue","year":"2019","unstructured":"Xue S, Liu D, Zhu W, Su Z, Zhang L, Zhou C, et al. Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p are novel biomarkers for diagnosis of acute myocardial infarction. Front Physiol. 2019;10:123.","journal-title":"Front Physiol"},{"key":"1753_CR7","doi-asserted-by":"publisher","first-page":"1215802","DOI":"10.1155\/2020\/1215802","volume":"2020","author":"AE Berezin","year":"2020","unstructured":"Berezin AE, Berezin AA. Adverse cardiac remodelling after acute myocardial infarction: old and new biomarkers. Dis Markers. 2020;2020:1215802.","journal-title":"Dis Markers"},{"key":"1753_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.yjmcc.2021.12.007","volume":"165","author":"Z Onodi","year":"2022","unstructured":"Onodi Z, Visnovitz T, Kiss B, Hambalko S, Koncz A, Agg B, et al. Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac phenotype. J Mol Cell Cardiol. 2022;165:19\u201330.","journal-title":"J Mol Cell Cardiol"},{"key":"1753_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.omto.2022.03.002","volume":"25","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Wang Z, Gao J, Lin Z, Wang Y, Shan P, et al. Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma. Mol Ther Oncolytics. 2022;25:98\u2013120.","journal-title":"Mol Ther Oncolytics"},{"key":"1753_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12967-018-1582-8","volume":"16","author":"J Cheng","year":"2018","unstructured":"Cheng J, Zhuo H, Xu M, Wang L, Xu H, Peng J, et al. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer. J Transl Med. 2018;16:216.","journal-title":"J Transl Med"},{"key":"1753_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391.","journal-title":"Nat Rev Genet"},{"key":"1753_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.omtn.2021.10.002","volume":"26","author":"ZJ Wen","year":"2021","unstructured":"Wen ZJ, Xin H, Wang YC, Liu HW, Gao YY, Zhang YF. Emerging roles of circRNAs in the pathological process of myocardial infarction. Mol Ther Nucleic Acids. 2021;26:828\u201348.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1753_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3892\/etm.2021.10228","volume":"22","author":"C Cheng","year":"2021","unstructured":"Cheng C, Xu DL, Liu XB, Bi SJ, Zhang J. MicroRNA-145-5p inhibits hypoxia\/reoxygenation-induced apoptosis in H9c2 cardiomyocytes by targeting ROCK1. Exp Ther Med. 2021;22:796.","journal-title":"Exp Ther Med"},{"key":"1753_CR14","doi-asserted-by":"publisher","first-page":"42916","DOI":"10.1038\/srep42916","volume":"7","author":"J Faccini","year":"2017","unstructured":"Faccini J, Ruidavets JB, Cordelier P, Martins F, Maoret JJ, Bongard V, et al. Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease. Sci Rep. 2017;7:42916.","journal-title":"Sci Rep"},{"key":"1753_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/0366-6999.196573","volume":"130","author":"M Zhang","year":"2017","unstructured":"Zhang M, Cheng YJ, Sara JD, Liu LJ, Liu LP, Zhao X, et al. Circulating microRNA-145 is associated with acute myocardial infarction and heart failure. Chin Med J (Engl). 2017;130:51\u20136.","journal-title":"Chin Med J (Engl)"},{"key":"1753_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.21037\/atm-20-4227","volume":"8","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Liu X, Hao S, He Q, Shen Z. Plasma levels of miR-143 and miR-145 are associated with coronary in-stent restenosis within 1 year of follow-up after drug-eluting stent implantation. Ann Transl Med. 2020;8:756.","journal-title":"Ann Transl Med"},{"key":"1753_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.omtn.2020.10.037","volume":"23","author":"W Yang","year":"2021","unstructured":"Yang W, Yin R, Zhu X, Yang S, Wang J, Zhou Z, et al. Mesenchymal stem-cell-derived exosomal miR-145 inhibits atherosclerosis by targeting JAM-A. Mol Ther Nucleic Acids. 2021;23:119\u201331.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1753_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00380-022-02172-2","volume":"38","author":"L Xu","year":"2023","unstructured":"Xu L, Tian L, Yan Z, Wang J, Xue T, Sun Q. Diagnostic and prognostic value of miR-486-5p, miR-451a, miR-21-5p and monocyte to high-density lipoprotein cholesterol ratio in patients with acute myocardial infarction. Heart Vessels. 2023;38:318\u201331.","journal-title":"Heart Vessels"},{"key":"1753_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40001-020-00403-8","volume":"25","author":"S Wu","year":"2020","unstructured":"Wu S, Sun H, Sun B. MicroRNA-145 is involved in endothelial cell dysfunction and acts as a promising biomarker of acute coronary syndrome. Eur J Med Res. 2020;25:2.","journal-title":"Eur J Med Res"},{"key":"1753_CR20","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.3390\/ijms22094799","volume":"22","author":"AI Scarlatescu","year":"2021","unstructured":"Scarlatescu AI, Micheu MM, Popa-Fotea NM, Dorobantu M. MicroRNAs in Acute ST elevation myocardial infarction\u2014a new tool for diagnosis and prognosis: therapeutic implications. Int J Mol Sci. 2021;22:4799.","journal-title":"Int J Mol Sci"},{"key":"1753_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clinbiochem.2022.10.004","volume":"111","author":"L Meng","year":"2023","unstructured":"Meng L, Yu X, Han H, Jia X, Hu B, Zhang L, et al. Circulating miR-143 and miR-145 as promising biomarkers for evaluating severity of coronary artery stenosis in patients with acute coronary syndrome. Clin Biochem. 2023;111:32\u201340.","journal-title":"Clin Biochem"},{"key":"1753_CR22","doi-asserted-by":"publisher","first-page":"H1813","DOI":"10.1152\/ajpheart.00709.2014","volume":"309","author":"K Higashi","year":"2015","unstructured":"Higashi K, Yamada Y, Minatoguchi S, Baba S, Iwasa M, Kanamori H, et al. MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy. Am J Physiol Heart Circ Physiol. 2015;309:H1813\u201326.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1753_CR23","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/CIRCULATIONAHA.118.038361","volume":"139","author":"S Huang","year":"2019","unstructured":"Huang S, Li X, Zheng H, Si X, Li B, Wei G, et al. loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139:2857\u201376.","journal-title":"Circulation"},{"key":"1753_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.omto.2020.03.012","volume":"17","author":"J Cheng","year":"2020","unstructured":"Cheng J, Zhuo H, Wang L, Zheng W, Chen X, Hou J, et al. Identification of the combinatorial effect of miRNA family regulatory network in different growth patterns of GC. Mol Ther Oncolytics. 2020;17:531\u201346.","journal-title":"Mol Ther Oncolytics"},{"key":"1753_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.626492","volume":"11","author":"C Zhao","year":"2020","unstructured":"Zhao C, Liu J, Ge W, Li Z, Lv M, Feng Y, et al. Identification of regulatory circRNAs involved in the pathogenesis of acute myocardial infarction. Front Genet. 2020;11: 626492.","journal-title":"Front Genet"},{"key":"1753_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41556-021-00639-4","volume":"23","author":"X Gao","year":"2021","unstructured":"Gao X, Xia X, Li F, Zhang M, Zhou H, Wu X, et al. Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling. Nat Cell Biol. 2021;23:278\u201391.","journal-title":"Nat Cell Biol"},{"key":"1753_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tig.2022.08.004","volume":"39","author":"B Ren","year":"2023","unstructured":"Ren B, Guan MX, Zhou T, Cai X, Shan G. Emerging functions of mitochondria-encoded noncoding RNAs. Trends Genet. 2023;39:125\u201339.","journal-title":"Trends Genet"},{"issue":"242\u201360","key":"1753_CR28","volume":"178","author":"S van Heesch","year":"2019","unstructured":"van Heesch S, Witte F, Schneider-Lunitz V, Schulz JF, Adami E, Faber AB, et al. The translational landscape of the human heart. Cell. 2019;178(242\u201360): e29.","journal-title":"Cell"},{"issue":"631\u201349","key":"1753_CR29","first-page":"vi","volume":"27","author":"TJ Pollard","year":"2000","unstructured":"Pollard TJ. The acute myocardial infarction. Prim Care. 2000;27(631\u201349):vi.","journal-title":"Prim Care"},{"key":"1753_CR30","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1093\/eurheartj\/ehv713","volume":"37","author":"K Wang","year":"2016","unstructured":"Wang K, Long B, Liu F, Wang JX, Liu CY, Zhao B, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J. 2016;37:2602\u201311.","journal-title":"Eur Heart J"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-01753-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T09:08:53Z","timestamp":1710493733000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-01753-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-01753-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"20 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were in accordance with the Declaration of Helsinki of 1964 (2013 revision). Informed consent or an accepted substitute was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}